UPDATED May 20, 2024
Even though biotechnology stocks can be very risky, they can also offer some of the biggest rewards with huge profits on offer when you find the right one. The companies below all have reasonable balance sheets and value, giving the best chance of finding a gem.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
SLV | zł70.50 | 1.1% | -9.1% | zł1.3b | zł68.98 | PE18.5x | E12.2% | n/a | ||
RVU | zł54.50 | 7.7% | -8.7% | zł1.3b | zł73.13 | PS16.9x | E-9.9% | n/a | ||
BIO | zł3.51 | -1.5% | -5.0% | zł301.0m | n/a | PS1.6x | n/a | n/a | ||
MAB | zł18.18 | -0.1% | -0.4% | zł293.8m | zł15.83 | PE6.9x | E-111.9% | n/a | ||
MOC | zł14.76 | -4.8% | -29.4% | zł248.5m | zł34.00 | PS180.6x | E-6.3% | n/a | ||
BGD | zł20.40 | -10.5% | 45.7% | zł59.0m | n/a | PE11.3x | n/a | 2.0% | ||
RDG | zł4.99 | -2.5% | 51.2% | zł58.8m | n/a | PS5.5x | n/a | n/a | ||
MDB | zł0.85 | -2.5% | -16.7% | zł58.3m | n/a | PS42.5x | n/a | n/a | ||
PUR | zł7.40 | -0.1% | -56.5% | zł24.6m | n/a | PS225.9x | n/a | n/a | ||
GX1 | zł6.00 | -6.3% | -40.6% | zł20.2m | n/a | PS9.8x | n/a | 0% | ||
LCN | zł0.41 | -3.6% | -10.8% | zł8.8m | n/a | PS98.5x | n/a | n/a |